What Is Lymphoma? Adolescent and Young Adult Lymphoma › Chronic Lymphocytic Leukemia › Hodgkin Lymphoma › Non-Hodgkin Lymphoma › LEARN MORE
What resources are available? Booklets and Fact Sheets › Education Programs › LRF Helpline › Lymphoma Support Network › Mobile App › LEARN MORE
What can I do to help? Accelerate Lymphoma Research › Attend an Event › Become an Advocate › Join Team LRF › Volunteer as a buddy › Ways to Give › LEARN MORE
EVERY 5 MINUTES SOMEONE IN THE U.S. IS DIAGNOSED WITH LYMPHOMA. Learn more about our impact $60 MILLION THE LYMPHOMA RESEARCH FOUNDATION HAS FUNDED NEARLY Learn more about our impact on research IN LYMPHOMA-SPECIFIC RESEARCH. 10,000 LRF’S TRAINED SOCIAL WORKERS PROVIDE INDIVIDUAL SUPPORT AND INFORMATION TO NEARLY Contact the LRF Helpline PATIENTS EACH YEAR Accelerate the pace of lymphoma research. $ Accelerate the pace of lymphoma research. $ STORIES OF HOPE View all › LAUREN, DLBCL SURVIVOR › "My new word is PERSEVERE" JUSTINE, HL SURVIVOR › "I think lymphoma has made me a more kind and caring person." MATT, FL SURVIVOR › "I was only 36, still in good health, still going to the gym every day." MICHELLE, DLBCL CAREGIVER › "AJ was diagnosed with B-cell lymphoma, and our world stopped turning."
Research News ASH 2018: CAR T-Cell Trials in DLBCL, FL Reflect Continued Promise 2/11/2019 Updated results from the JULIET trial, testing tisagenlecleucel (Kymriah) in relapsed or refractory diffuse large B-cell lymphoma (DLBCL), revealed encouraging long term results.
Lymphoma News ECHELON-2 Trial Demonstrates “Practice-Changing” Results for Peripheral T-Cell Lymphomas
